271 related articles for article (PubMed ID: 32616477)
1. Toward a New Molecular Taxonomy of Diffuse Large B-cell Lymphoma.
Ennishi D; Hsi ED; Steidl C; Scott DW
Cancer Discov; 2020 Sep; 10(9):1267-1281. PubMed ID: 32616477
[TBL] [Abstract][Full Text] [Related]
2. Evolving insights into the genomic complexity and immune landscape of diffuse large B-cell lymphoma: opportunities for novel biomarkers.
El Hussein S; Shaw KRM; Vega F
Mod Pathol; 2020 Dec; 33(12):2422-2436. PubMed ID: 32620919
[TBL] [Abstract][Full Text] [Related]
3. A Probabilistic Classification Tool for Genetic Subtypes of Diffuse Large B Cell Lymphoma with Therapeutic Implications.
Wright GW; Huang DW; Phelan JD; Coulibaly ZA; Roulland S; Young RM; Wang JQ; Schmitz R; Morin RD; Tang J; Jiang A; Bagaev A; Plotnikova O; Kotlov N; Johnson CA; Wilson WH; Scott DW; Staudt LM
Cancer Cell; 2020 Apr; 37(4):551-568.e14. PubMed ID: 32289277
[TBL] [Abstract][Full Text] [Related]
4. Diffuse large B-cell lymphoma.
Li S; Young KH; Medeiros LJ
Pathology; 2018 Jan; 50(1):74-87. PubMed ID: 29167021
[TBL] [Abstract][Full Text] [Related]
5. Diffuse Large B-Cell Lymphoma and High-Grade B-Cell Lymphoma: Genetic Classification and Its Implications for Prognosis and Treatment.
Crombie JL; Armand P
Hematol Oncol Clin North Am; 2019 Aug; 33(4):575-585. PubMed ID: 31229155
[TBL] [Abstract][Full Text] [Related]
6. Intra-tumour heterogeneity of diffuse large B-cell lymphoma involves the induction of diversified stroma-tumour interfaces.
Sangaletti S; Iannelli F; Zanardi F; Cancila V; Portararo P; Botti L; Vacca D; Chiodoni C; Di Napoli A; Valenti C; Rizzello C; Vegliante MC; Pisati F; Gulino A; Ponzoni M; Colombo MP; Tripodo C
EBioMedicine; 2020 Nov; 61():103055. PubMed ID: 33096480
[TBL] [Abstract][Full Text] [Related]
7. Molecular heterogeneity in diffuse large B-cell lymphoma and its implications in clinical diagnosis and treatment.
Guo L; Lin P; Xiong H; Tu S; Chen G
Biochim Biophys Acta Rev Cancer; 2018 Apr; 1869(2):85-96. PubMed ID: 29337112
[TBL] [Abstract][Full Text] [Related]
8. Understanding the Cause and Consequence of Tumor Heterogeneity.
Khatib S; Pomyen Y; Dang H; Wang XW
Trends Cancer; 2020 Apr; 6(4):267-271. PubMed ID: 32209440
[TBL] [Abstract][Full Text] [Related]
9. Diffuse Large B-Cell Lymphoma and High-Grade B-Cell Lymphoma: Genetic Classification and Its Implications for Prognosis and Treatment.
Crombie JL; Armand P
Surg Oncol Clin N Am; 2020 Jan; 29(1):115-125. PubMed ID: 31757308
[TBL] [Abstract][Full Text] [Related]
10. Diffuse Large B-cell lymphoma: Prognostic markers and their impact on therapy.
Jamil MO; Mehta A
Expert Rev Hematol; 2016 May; 9(5):471-7. PubMed ID: 26808217
[TBL] [Abstract][Full Text] [Related]
11. Prediction of survival in diffuse large B-cell lymphoma based on the expression of 2 genes reflecting tumor and microenvironment.
Alizadeh AA; Gentles AJ; Alencar AJ; Liu CL; Kohrt HE; Houot R; Goldstein MJ; Zhao S; Natkunam Y; Advani RH; Gascoyne RD; Briones J; Tibshirani RJ; Myklebust JH; Plevritis SK; Lossos IS; Levy R
Blood; 2011 Aug; 118(5):1350-8. PubMed ID: 21670469
[TBL] [Abstract][Full Text] [Related]
12. Molecular classification, pathway addiction, and therapeutic targeting in diffuse large B cell lymphoma.
Puvvada S; Kendrick S; Rimsza L
Cancer Genet; 2013; 206(7-8):257-65. PubMed ID: 24080457
[TBL] [Abstract][Full Text] [Related]
13. Clinical impact of molecular features in diffuse large B-cell lymphoma and follicular lymphoma.
Pon JR; Marra MA
Blood; 2016 Jan; 127(2):181-6. PubMed ID: 26447189
[TBL] [Abstract][Full Text] [Related]
14. Predictive and Prognostic Molecular Factors in Diffuse Large B-Cell Lymphomas.
Pileri SA; Tripodo C; Melle F; Motta G; Tabanelli V; Fiori S; Vegliante MC; Mazzara S; Ciavarella S; Derenzini E
Cells; 2021 Mar; 10(3):. PubMed ID: 33803671
[TBL] [Abstract][Full Text] [Related]
15. New strategies in diffuse large B-cell lymphoma: translating findings from gene expression analyses into clinical practice.
Friedberg JW
Clin Cancer Res; 2011 Oct; 17(19):6112-7. PubMed ID: 21844008
[TBL] [Abstract][Full Text] [Related]
16. Advances in the molecular diagnosis of diffuse large B-cell lymphoma in the era of precision medicine.
Araf S; Korfi K; Rahim T; Davies A; Fitzgibbon J
Expert Rev Mol Diagn; 2016 Oct; 16(10):1093-1102. PubMed ID: 27648481
[TBL] [Abstract][Full Text] [Related]
17. Molecular Subtyping in Diffuse Large B Cell Lymphoma: Closer to an Approach of Precision Therapy.
Karmali R; Gordon LI
Curr Treat Options Oncol; 2017 Feb; 18(2):11. PubMed ID: 28229364
[TBL] [Abstract][Full Text] [Related]
18. Precision Medicine for Diffuse Large B-cell Lymphoma.
Lim MS; Elenitoba-Johnson KS
Clin Cancer Res; 2016 Jun; 22(12):2829-31. PubMed ID: 26988247
[TBL] [Abstract][Full Text] [Related]
19. Diffuse large B cell lymphoma: using pathologic and molecular biomarkers to define subgroups for novel therapy.
Carbone A; Gloghini A; Kwong YL; Younes A
Ann Hematol; 2014 Aug; 93(8):1263-77. PubMed ID: 24870942
[TBL] [Abstract][Full Text] [Related]
20. Molecular profiling in diffuse large B-cell lymphoma: why so many types of subtypes?
Morin RD; Arthur SE; Hodson DJ
Br J Haematol; 2022 Feb; 196(4):814-829. PubMed ID: 34467527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
